ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

NCI-Approved Clinical Trials

July 25, 2003

Bypass Budget For FY 1992 Shown In Chart

May 18, 1990

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003